NICE Guidelines for Managing Neuropathic Pain in Non-Specialist Settings

Neuropathic pain can be a challenging condition to manage, especially in non-specialist settings. To help healthcare professionals provide effective treatment, the National Institute for Health and Care Excellence (NICE) has published guidelines on the pharmacological management of neuropathic pain.

The key points of the guidelines are as follows:

– For all neuropathic pain (except trigeminal neuralgia), offer a choice of amitriptyline, duloxetine, gabapentin, or pregabalin as initial treatment.
– If the initial treatment is not effective or not tolerated, offer one of the remaining three drugs and consider switching again if necessary.
– Consider tramadol only if acute rescue therapy is needed.
– Consider capsaicin cream for people with localised neuropathic pain who wish to avoid or cannot tolerate oral treatments.

By following these guidelines, healthcare professionals can provide effective treatment for neuropathic pain and improve the quality of life for their patients.

GMC Study Finds Low Rate of Severe Prescription Errors

A recent study conducted by the General Medical Council (GMC) aimed to assess the prevalence of severe prescription errors in primary healthcare settings. The study utilized systemic reviews of literature, patient record assessments, root cause analysis, focus groups, and interviews with healthcare professionals. The results showed that only 0.18% of prescriptions were associated with severe errors, with the majority of errors related to warfarin prescribing and patients being prescribed medications they were allergic to.

The study, known as the PRACtICe study, provides valuable insights and learning points that may be tested in exams. It is recommended that individuals familiarize themselves with the study summary and conclusions in chapter 10 of the report. Overall, the study highlights the importance of ensuring accurate and safe prescribing practices in primary healthcare settings.

It is important to distinguish between upper and lower urinary tract infections as the choice and duration of antibiotic treatment differ. Localising symptoms can guide treatment in primary care. In young children with confirmed UTI, clinicians may be tempted to treat for 5 or 7 days simply because of their age, but there are clear guidelines on this. A urine specimen should be collected for culture and sensitivity testing before starting antibacterial therapy, especially in children under 3 years of age, those with suspected upper urinary-tract infection, complicated infection, or recurrent infection, and pregnant women. Treatment should not be delayed while waiting for results, and the chosen antibacterial should reflect current local bacterial sensitivity. Uncomplicated lower urinary tract infections in children over 3 months of age can be treated with various antibiotics for 3 days, while acute pyelonephritis in children over 3 months of age can be treated with a first-generation cephalosporin or co-amoxiclav for 7-10 days. Children under 3 months of age should be transferred to hospital and treated initially with intravenous antibacterials until the infection responds.

Urinary Tract Infection in Children: Symptoms, Diagnosis, and Treatment

Urinary tract infections (UTIs) are more common in boys until 3 months of age, after which the incidence is substantially higher in girls. At least 8% of girls and 2% of boys will have a UTI in childhood. The presentation of UTIs in childhood depends on age. Infants may experience poor feeding, vomiting, and irritability, while younger children may have abdominal pain, fever, and dysuria. Older children may experience dysuria, frequency, and haematuria. Features that may suggest an upper UTI include a temperature of over 38ºC and loin pain or tenderness.

According to NICE guidelines, a urine sample should be checked in a child if there are any symptoms or signs suggestive of a UTI, with unexplained fever of 38°C or higher (test urine after 24 hours at the latest), or with an alternative site of infection but who remain unwell (consider urine test after 24 hours at the latest). A clean catch is the preferable method for urine collection. If not possible, urine collection pads should be used. Invasive methods such as suprapubic aspiration should only be used if non-invasive methods are not possible.

Infants less than 3 months old should be referred immediately to a paediatrician. Children aged more than 3 months old with an upper UTI should be considered for admission to the hospital. If not admitted, oral antibiotics such as cephalosporin or co-amoxiclav should be given for 7-10 days. Children aged more than 3 months old with a lower UTI should be treated with oral antibiotics for 3 days according to local guidelines, usually trimethoprim, nitrofurantoin, cephalosporin, or amoxicillin. Parents should be asked to bring the children back if they remain unwell after 24-48 hours. Antibiotic prophylaxis is not given after the first UTI but should be considered with recurrent UTIs.

Molluscum Contagiosum: Symptoms, Treatment, and Underlying Causes

Molluscum contagiosum is a viral skin infection caused by a DNA pox virus. It is characterized by small, dome-shaped papules with a central punctum that may appear umbilicated. Squeezing the lesions can release a cheesy material. While the infection usually resolves on its own within 12-18 months, patients may opt for treatment if they find the rash unsightly. Squeezing the lesions can speed up resolution.

However, if a patient presents with hundreds of widespread lesions, it is important to investigate any underlying immunodeficiency problems. This may include conditions such as HIV/AIDS. Further investigation is necessary to determine the cause of the extensive rash.

When evaluating research articles, it is crucial to be aware of various biases and assess whether they have been minimized. If an article exhibits bias, its results may not be reliable. Some types of bias include response bias, where those who participate in a study may not accurately represent the population; observer bias, where the outcome may be influenced by the observer’s subjectivity; publication bias, where studies with negative findings are less likely to be published; and recall bias, where patients may more easily remember exposures they believe are linked to the outcome.

Detecting Publication Bias with Funnel Plots

Publication bias is a common issue in research where only studies with positive results are published, leading to biased overall results. To detect publication bias, graphical methods such as funnel plots and Galbraith plots can be used.

Among these methods, the funnel plot is the most commonly used and important for exams. A funnel plot is a scatter graph used to check for publication bias in systematic reviews and meta-analyses. It provides a visual representation of the weight of published literature, ensuring that all studies are evenly represented.

An asymmetrical, inverted funnel shape in a funnel plot indicates that publication bias is unlikely. However, an asymmetrical funnel shape indicates a relationship between treatment effect and study size, suggesting either publication bias or a systematic difference between smaller and larger studies known as small study effects. Therefore, funnel plots are a valuable tool for detecting publication bias and ensuring unbiased research results.

Lithium is a drug used to stabilize mood in patients with bipolar disorder and refractory depression. It has a narrow therapeutic range of 0.4-1.0 mmol/L and is primarily excreted by the kidneys. Lithium toxicity occurs when the concentration exceeds 1.5 mmol/L, which can be caused by dehydration, renal failure, and certain drugs such as diuretics, ACE inhibitors, NSAIDs, and metronidazole. Symptoms of toxicity include coarse tremors, hyperreflexia, acute confusion, polyuria, seizures, and coma.

To manage mild to moderate toxicity, volume resuscitation with normal saline may be effective. Severe toxicity may require hemodialysis. Sodium bicarbonate may also be used to increase the alkalinity of the urine and promote lithium excretion, but there is limited evidence to support its use. It is important to monitor lithium levels closely and adjust the dosage accordingly to prevent toxicity.

Oseltamivir (Tamiflu) for Prophylactic Treatment during Flu Epidemics

During flu epidemics, oseltamivir (Tamiflu) may be used as a prophylactic treatment for at-risk patients, including pregnant women. However, long-term use of oseltamivir can lead to resistance. The current protocol recommends no antiviral treatment for previously healthy individuals, unless the physician deems the patient at serious risk of developing complications from the flu. In such cases, oseltamivir may be prescribed orally.

For at-risk populations, including pregnant women (excluding the severely immunosuppressed), oseltamivir is recommended as a prophylactic treatment. Treatment should begin as soon as possible, ideally within 48 hours of onset. Evidence suggests that even if treatment is started up to 5 days after onset, it may reduce the risk of mortality. However, starting treatment more than 48 hours after onset is considered an off-label use of oseltamivir, and clinical judgement should be exercised.

For the full protocol, please refer to the HM UK Government’s guidelines on influenza treatment and prophylaxis using antiviral agents.

Pulmonary embolism (PE) is a serious medical condition that can lead to a range of symptoms and complications. One of the most common signs of PE is an elevated heart rate, which can be caused by the increased demand on the right ventricle of the heart. This can lead to a range of other symptoms, including shortness of breath, chest pain, and coughing.

Another common sign of PE is the presence of S1Q3T3 on an electrocardiogram (ECG). This is characterized by a deep S-wave in lead I, a Q-wave in lead III, and an inverted T-wave in lead III. While this finding is associated with PE, it is not specific to the condition and may not be present in all cases.

T-wave inversions in leads V1-V4 can also be a sign of right ventricular strain, which can occur as a result of the increased demand on the heart caused by PE. However, this is not the most common finding in cases of PE.

Pulmonary embolism can be difficult to diagnose as it can present with a variety of cardiorespiratory symptoms and signs depending on its location and size. The PIOPED study in 2007 found that tachypnea, crackles, tachycardia, and fever were common clinical signs in patients diagnosed with pulmonary embolism. The Well’s criteria for diagnosing a PE use tachycardia rather than tachypnea. All patients with symptoms or signs suggestive of a PE should have a history taken, examination performed, and a chest x-ray to exclude other pathology.

To rule out a PE, the pulmonary embolism rule-out criteria (PERC) can be used. All criteria must be absent to have a negative PERC result, which reduces the probability of PE to less than 2%. If the suspicion of PE is greater than this, a 2-level PE Wells score should be performed. A score of more than 4 points indicates a likely PE, and an immediate computed tomography pulmonary angiogram (CTPA) should be arranged. If the CTPA is negative, patients do not need further investigations or treatment for PE.

CTPA is now the recommended initial lung-imaging modality for non-massive PE. V/Q scanning may be used initially if appropriate facilities exist, the chest x-ray is normal, and there is no significant symptomatic concurrent cardiopulmonary disease. D-dimer levels should be considered for patients over 50 years old. A chest x-ray is recommended for all patients to exclude other pathology, but it is typically normal in PE. The sensitivity of V/Q scanning is around 75%, while the specificity is 97%. Peripheral emboli affecting subsegmental arteries may be missed on CTPA.

Contraindication of Sildenafil with Nitrates

Sildenafil should not be taken by patients who are also taking nitrates or nitrate derivatives such as nicorandil. If a patient is taking nitrates, they should stop taking them during the period when they are using sildenafil. This is because the combination of sildenafil and nitrates can cause a dangerous drop in blood pressure, which can lead to serious health complications. It is important for patients to inform their healthcare provider of all medications they are taking before starting sildenafil to avoid any potential contraindications.

Smoking cessation is the process of quitting smoking. In 2008, NICE released guidance on how to manage smoking cessation. The guidance recommends that patients should be offered nicotine replacement therapy (NRT), varenicline or bupropion, and that clinicians should not favour one medication over another. These medications should be prescribed as part of a commitment to stop smoking on or before a particular date, and the prescription should only last until 2 weeks after the target stop date. If unsuccessful, a repeat prescription should not be offered within 6 months unless special circumstances have intervened. NRT can cause adverse effects such as nausea and vomiting, headaches, and flu-like symptoms. NICE recommends offering a combination of nicotine patches and another form of NRT to people who show a high level of dependence on nicotine or who have found single forms of NRT inadequate in the past.

Varenicline is a nicotinic receptor partial agonist that should be started 1 week before the patient’s target date to stop. The recommended course of treatment is 12 weeks, but patients should be monitored regularly and treatment only continued if not smoking. Varenicline has been shown in studies to be more effective than bupropion, but it should be used with caution in patients with a history of depression or self-harm. Nausea is the most common adverse effect, and varenicline is contraindicated in pregnancy and breastfeeding.

Bupropion is a norepinephrine and dopamine reuptake inhibitor, and nicotinic antagonist that should be started 1 to 2 weeks before the patient’s target date to stop. There is a small risk of seizures, and bupropion is contraindicated in epilepsy, pregnancy, and breastfeeding. Having an eating disorder is a relative contraindication.

In 2010, NICE recommended that all pregnant women should be tested for smoking using carbon monoxide detectors. All women who smoke, or have stopped smoking within the last 2 weeks, or those with a CO reading of 7 ppm or above should be referred to NHS Stop Smoking Services. The first-line interventions in pregnancy should be cognitive behaviour therapy, motivational interviewing, or structured self-help and support from NHS Stop Smoking Services. The evidence for the use of NRT in pregnancy is mixed, but it is often used if the above measures fail. There is no evidence that it affects the child’s birthweight. Pregnant women

Routine Childhood Immunisation Schedule

The routine childhood immunisation schedule is a crucial aspect of healthcare for young children. It protects them from a range of diseases that can cause serious harm or even death. The schedule includes vaccinations for diphtheria, tetanus, pertussis, polio, Hib, hepatitis B, pneumococcal disease, meningococcal group B, and rotavirus.

At 8 weeks, infants receive vaccinations for diphtheria, tetanus, pertussis, polio, Hib, hepatitis B, pneumococcal disease, meningococcal group B, and oral rotavirus. At 12 weeks, they receive vaccinations for diphtheria, tetanus, pertussis, polio, Hib, and oral rotavirus. At 16 weeks, they receive vaccinations for diphtheria, tetanus, pertussis, polio, Hib, hepatitis B, pneumococcal disease, and meningococcal group B.

It is important to note that the hepatitis B immunisation was added to the routine schedule in 2017, but not hepatitis A. Additionally, pneumococcal immunisation is given at 8 and 16 weeks, but not at 12 weeks, while meningococcal B immunisation is given at 8 and 16 weeks, but not at 12 weeks. Understanding the routine childhood immunisation schedule is crucial for healthcare professionals and parents alike to ensure the health and safety of young children.

If a woman has a suspected or personal history of breast cancer or a confirmed BRCA mutation, the safest form of contraception for her is the copper coil. The UK Medical Eligibility Criteria for Contraceptive Use (UKMEC) provides guidelines for the choice of contraception, grading non-barrier contraceptives on a scale of 1-4 based on a woman’s personal circumstances. Contraceptive methods that fall under category 1 or 2 are generally considered safe for use in primary care. In this case, all forms of contraception except the combined pill (category 3) can be offered, with the copper coil being the safest option as it falls under category 1.

Understanding Contraception: A Basic Overview

Contraception has come a long way in the past 50 years, with the development of effective methods being one of the most significant advancements in medicine. There are various types of contraception available, including barrier methods, daily methods, and long-acting methods of reversible contraception (LARCs).

Barrier methods, such as condoms, act as a physical barrier and can help protect against sexually transmitted infections (STIs). However, their success rate is relatively low, particularly when used by young people. Daily methods include the combined oral contraceptive pill, which inhibits ovulation but increases the risk of venous thromboembolism and certain types of cancer. The progesterone-only pill thickens cervical mucous, but irregular bleeding is a common side effect.

LARCs include implantable contraceptives, injectable contraceptives, and intrauterine devices (IUDs). The implantable contraceptive and injectable contraceptive both inhibit ovulation and thicken cervical mucous, with the implant lasting up to three years and the injection lasting 12 weeks. The IUD decreases sperm motility and survival, while the intrauterine system (IUS) prevents endometrial proliferation and thickens cervical mucous, with irregular bleeding being a common side effect.

In summary, understanding the different types of contraception available and their methods of action can help individuals make informed decisions about their reproductive health.

Acute hepatitis A is characterized by symptoms similar to those of other forms of acute viral hepatitis, including flu-like symptoms, RUQ pain, tender hepatomegaly, and abnormal liver function tests. It is difficult to differentiate hepatitis A from other forms of viral hepatitis based on medical history, physical examination, or routine laboratory tests. However, a history of exposure or risk factors, such as travel to regions with high prevalence, can increase suspicion. Unlike hepatitis C and D, which are transmitted through blood, hepatitis A is transmitted through the fecal-oral route.

Understanding Hepatitis A: Symptoms, Transmission, and Prevention

Hepatitis A is a viral infection that affects the liver. It is usually a mild illness that resolves on its own, with serious complications being rare. The virus is transmitted through the faecal-oral route, often in institutions. The incubation period is typically 2-4 weeks, and symptoms include a flu-like prodrome, abdominal pain (usually in the right upper quadrant), tender hepatomegaly, jaundice, and deranged liver function tests.

While complications are rare, there is no increased risk of hepatocellular cancer. An effective vaccine is available, and it is recommended for people travelling to or residing in areas of high or intermediate prevalence, those with chronic liver disease, patients with haemophilia, men who have sex with men, injecting drug users, and individuals at occupational risk (such as laboratory workers, staff of large residential institutions, sewage workers, and people who work with primates).

It is important to note that the vaccine requires a booster dose 6-12 months after the initial dose. By understanding the symptoms, transmission, and prevention of hepatitis A, individuals can take steps to protect themselves and others from this viral infection.

Patients with mechanical heart valves should avoid using dabigatran due to its increased risk of bleeding and thrombotic events compared to warfarin. The MHRA has deemed it contraindicated for this population.

Dabigatran: An Oral Anticoagulant with Two Main Indications

Dabigatran is an oral anticoagulant that directly inhibits thrombin, making it an alternative to warfarin. Unlike warfarin, dabigatran doesn’t require regular monitoring. It is currently used for two main indications. Firstly, it is an option for prophylaxis of venous thromboembolism following hip or knee replacement surgery. Secondly, it is licensed for prevention of stroke in patients with non-valvular atrial fibrillation who have one or more risk factors present. The major adverse effect of dabigatran is haemorrhage, and doses should be reduced in chronic kidney disease. Dabigatran should not be prescribed if the creatinine clearance is less than 30 ml/min. In cases where rapid reversal of the anticoagulant effects of dabigatran is necessary, idarucizumab can be used. However, the RE-ALIGN study showed significantly higher bleeding and thrombotic events in patients with recent mechanical heart valve replacement using dabigatran compared with warfarin. As a result, dabigatran is now contraindicated in patients with prosthetic heart valves.

Managing Worsening Asthma Symptoms: Starting Inhaled Corticosteroids

This patient’s asthma symptoms have worsened, likely due to exposure to allergens at the stable. While her chest is clear and her PEFR has only mildly dropped, her daily symptoms and use of SABA indicate poorly controlled asthma. The first step in managing her symptoms is to start an inhaled corticosteroid as part of the stepwise approach to asthma management. Urgent allergy testing or a home allergy testing kit are not necessary at this stage, and oral steroids are not yet indicated. Instead, allergen avoidance measures can be discussed. It is not necessary for the patient to stop working at the stable at this time.

Pernicious anaemia is a condition that results in a deficiency of vitamin B12 due to an autoimmune disorder affecting the gastric mucosa. The term pernicious refers to the gradual and subtle harm caused by the condition, which often leads to delayed diagnosis. While pernicious anaemia is the most common cause of vitamin B12 deficiency, other causes include atrophic gastritis, gastrectomy, and malnutrition. The condition is characterized by the presence of antibodies to intrinsic factor and/or gastric parietal cells, which can lead to reduced vitamin B12 absorption and subsequent megaloblastic anaemia and neuropathy.

Pernicious anaemia is more common in middle to old age females and is associated with other autoimmune disorders such as thyroid disease, type 1 diabetes mellitus, Addison’s, rheumatoid, and vitiligo. Symptoms of the condition include anaemia, lethargy, pallor, dyspnoea, peripheral neuropathy, subacute combined degeneration of the spinal cord, neuropsychiatric features, mild jaundice, and glossitis. Diagnosis is made through a full blood count, vitamin B12 and folate levels, and the presence of antibodies.

Management of pernicious anaemia involves vitamin B12 replacement, usually given intramuscularly. Patients with neurological features may require more frequent doses. Folic acid supplementation may also be necessary. Complications of the condition include an increased risk of gastric cancer.

Understanding Common Gastrointestinal Disorders: Differential Diagnosis

Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder affecting 10-20% of the UK population, with a higher incidence in females and those with underlying anxiety. Symptoms include abdominal pain or discomfort, bloating, and change in bowel habit lasting for at least six months. Defecation may provide relief, while eating can exacerbate symptoms. Other common symptoms include lethargy, nausea, backache, and bladder problems. Diagnosis is based on clinical presentation, as examination and investigations are typically normal.

Ulcerative colitis is a potential differential diagnosis if the patient presents with pain or blood in their stool. However, the long history of symptoms without significant systemic illness, normal examination, and links to stress/menstruation in this case suggest IBS. Normal inflammatory markers would support this diagnosis.

Chronic pancreatitis is characterized by persistent inflammation or damage, often linked to alcohol excess. The primary symptom is significant pain, which is not present in this case.

Diverticulitis is an acute presentation, with left iliac fossa pain, change in bowel habit, bleeding per rectum, and systemic illness. The chronic course, combination of symptoms, and normal examination make this diagnosis unlikely.

Peptic ulcer disease is also unlikely, as it typically causes pain linked to eating, nausea or vomiting, and is acute or progressive in nature. While stress can be a trigger, it is not the primary cause of this disorder.

Understanding Serotonin Syndrome

Serotonin syndrome is a condition that is often overlooked in primary care. It occurs when there is an excessive amount of serotonergic activity in the body, which can be caused by the initiation of medication affecting serotonin activity or an interaction between medicines that affect serotonin activity. Patients who take medications such as codeine, triptans, and St. John’s wort are at a higher risk of developing serotonin syndrome when co-prescribed with an SSRI.

If a patient presents with symptoms of serotonin syndrome, it is important to withdraw the offending medicine, such as Citalopram. However, it is also important to consider other factors that may have contributed to the onset of symptoms, such as the use of a triptan for a migraine. Prescribing pizotifen or referring the patient for counseling may not alleviate their symptoms.

It is important to note that some authorities caution against the use of propranolol, as it can result in hypotension and mask the response to treatment by slowing the pulse. By understanding the risk factors and symptoms of serotonin syndrome, healthcare providers can better diagnose and treat this condition.

Immunisations in Pregnancy

Pregnant women are advised to get immunised against influenza and pertussis, but there are some differences to note. The influenza vaccine is recommended during flu season and can be taken at any stage of pregnancy. On the other hand, the pertussis vaccine is recommended from 16 weeks and can be taken at any time of the year.

It is important for candidates to understand these differences and advise their patients accordingly. While there is no specific recommendation to immunise healthy pregnant women against HPV, MenACWY or pneumococcus, it is always best to consult with a healthcare professional to determine the best course of action for each individual case. By staying informed and up-to-date on immunisation recommendations, candidates can provide the best care for their patients during pregnancy.

Managing Measles Exposure in Pregnant Women

When a pregnant woman is exposed to measles, it is crucial for GPs to know how to respond appropriately. Simply reassuring her that no further action is necessary or to re-attend if she becomes unwell is not enough. Instead, GPs should offer an urgent blood test to check for measles IgG if there is no history of the patient receiving two doses of measles containing vaccine or if she is not known to be immune from previous measles disease.

If the patient is immune, GPs can reassure her that the risk of measles is low and advise her to contact her GP or midwife if she develops a rash. However, if the patient is non-immune and has been exposed within six days of onset of rash in the suspected or confirmed case, GPs can offer human normal immunoglobulin (HNIG) after checking IgG for measles first rather than giving HNIG empirically.

It is important to note that pregnant women should not be offered MMR vaccine. Measles infection in pregnancy can lead to intrauterine death and preterm delivery, and severe illness in the mother, but is not associated with congenital infection or damage. While HNIG may not prevent measles, it has been shown to attenuate the illness. However, there is no evidence that it prevents intrauterine death or preterm delivery. By following these guidelines, GPs can effectively manage measles exposure in pregnant women and prevent further harm.

In the event that a pregnant patient who is not immune is exposed to Chickenpox, it is recommended that she receive VZIG as soon as possible. VZIG can still be effective if administered within 10 days of contact, with the definition of continuous exposure being 10 days from the appearance of the rash in the initial case. If there is another exposure reported and at least 3 weeks have passed since the last dose, a second dose of VZIG may be necessary.

Chickenpox Exposure in Pregnancy: Risks and Management

Chickenpox is caused by the varicella-zoster virus and can pose risks to both the mother and fetus during pregnancy. The mother is at a five times greater risk of pneumonitis, while the fetus is at risk of developing fetal varicella syndrome (FVS) if the mother is exposed to Chickenpox before 20 weeks gestation. FVS can result in skin scarring, eye defects, limb hypoplasia, microcephaly, and learning disabilities. There is also a risk of shingles in infancy and severe neonatal varicella if the mother develops a rash between 5 days before and 2 days after birth.

To manage Chickenpox exposure in pregnancy, post-exposure prophylaxis (PEP) may be necessary. If the pregnant woman is not immune to varicella, VZIG or antivirals may be given within 10 days of exposure. Waiting until days 7-14 is recommended to reduce the risk of developing clinical varicella. However, the decision on choice of PEP for women exposed from 20 weeks of pregnancy should take into account patient and health professional preference as well as the ability to offer and provide PEP in a timely manner.

If a pregnant woman develops Chickenpox, specialist advice should be sought. Oral aciclovir may be given if the pregnant woman is ≥ 20 weeks and presents within 24 hours of onset of the rash. However, caution should be exercised if the woman is < 20 weeks. Overall, managing Chickenpox exposure in pregnancy requires careful consideration of the risks and benefits to both the mother and fetus.

Understanding Sunscreens: Protection Against UV Radiation

Sunscreens are essential in protecting the skin from the harmful effects of ultraviolet (UV) radiation from the sun. UVB causes sunburn, while UVA contributes to long-term photodamage, skin cancer, and aging. Sunscreens come in two types: chemical absorbers and physical blockers. Chemical absorbers absorb UVA or UVB, while physical blockers reflect or scatter UV radiation. The ideal sunscreens are those that provide the most effective protection against both UVA and UVB, but they may produce a white appearance when applied to the skin.

The sun protection factor (SPF) indicates the degree of protection against UVB. A higher SPF means longer protection against burning. However, users often do not apply enough sunscreen, resulting in lower protection than what is indicated in experimental studies. The EU Commission recommends that the UVA protection factor should be at least one-third of the SPF, and products that achieve this will be labelled with a UVA logo.

Sunscreens should be applied liberally to all exposed areas and reapplied every 2 hours, especially after swimming, sweating, or rubbing off. Allergic reactions to sunscreen are rare. Sunscreens can be prescribed and marked as ACBS drugs for individuals with genetic disorders, photodermatoses, vitiligo, changes resulting from radiotherapy, and chronic or recurrent herpes simplex labialis precipitated by sunlight. Sunscreens with SPF less than 30 should not normally be prescribed.

In summary, understanding sunscreens and their proper use is crucial in protecting the skin from the harmful effects of UV radiation.

For a child with croup, a single dose of oral dexamethasone (0.15 mg/kg) should be taken immediately regardless of the severity of the illness. Croup typically begins with cold-like symptoms and progresses to a barking cough with a seal-like sound. The severity of croup can be determined by the presence of symptoms such as stridor, recessions, and distress. In this case, the child has mild croup and hospital admission is not necessary. Nebulized adrenaline is only recommended for children with severe symptoms, while a salbutamol inhaler is not effective for croup. Antibiotics are not useful for treating croup as it is a viral illness. Steroids, such as dexamethasone, have been shown to alleviate symptoms and reduce the need for hospitalization.

Croup is a respiratory infection that affects young children, typically those between 6 months and 3 years old. It is most common in the autumn and is caused by parainfluenza viruses. The main symptom is stridor, which is caused by swelling and secretions in the larynx. Other symptoms include a barking cough, fever, and cold-like symptoms. The severity of croup can be graded based on the child’s symptoms, with mild cases having occasional coughing and no audible stridor at rest, and severe cases having frequent coughing, prominent stridor, and significant distress or lethargy. Children with moderate or severe croup should be admitted to the hospital, especially if they are under 6 months old or have other airway abnormalities. Diagnosis is usually made based on clinical symptoms, but a chest x-ray can show subglottic narrowing. Treatment typically involves a single dose of oral dexamethasone or prednisolone, and emergency treatment may include high-flow oxygen or nebulized adrenaline.

When a pregnant woman reports reduced fetal movements, it is important to investigate the cause as it can indicate a risk of stillbirth and fetal growth restriction. The first step in this investigation should be to use a handheld Doppler to confirm the presence of a fetal heartbeat.

If a fetal heartbeat is detected with the handheld Doppler and the pregnancy is over 28 weeks gestation, a CTG should be used to monitor the fetal heart rate for at least 20 minutes to assess for any fetal compromise.

The guidelines recommend assessing fetal movements based on the subjective perception of the mother. If a mother reports reduced fetal movements, there is no need for further counting of fetal movements.

If no fetal heartbeat is detected with the handheld Doppler, an immediate ultrasound should be offered. If there is still concern about reduced fetal movements despite a normal CTG, an urgent ultrasound can be used to assess abdominal circumference or estimated fetal weight and amniotic fluid volume measurement, rather than ultrasound with Doppler.

Understanding Reduced Fetal Movements

Reduced fetal movements can indicate fetal distress and are a cause for concern as they can lead to stillbirth and fetal growth restriction. It is believed that there may also be a link between reduced fetal movements and placental insufficiency. Fetal movements usually start between 18-20 weeks gestation and increase until 32 weeks gestation, after which the frequency of movement tends to plateau. Multiparous women may experience fetal movements sooner, from 16-18 weeks gestation. Fetal movements should not reduce towards the end of pregnancy.

There is no established definition for what constitutes reduced fetal movements, but the RCOG considers less than 10 movements within 2 hours (in pregnancies past 28 weeks gestation) an indication for further assessment. Reduced fetal movements are a fairly common presentation, affecting up to 15% of pregnancies. Risk factors for reduced fetal movements include posture, distraction, placental position, medication, fetal position, body habitus, amniotic fluid volume, and fetal size.

Investigations for reduced fetal movements are dependent on gestation at onset. If past 28 weeks gestation, handheld Doppler should be used to confirm fetal heartbeat. If no fetal heartbeat is detectable, immediate ultrasound should be offered. If fetal heartbeat is present, CTG should be used for at least 20 minutes to monitor fetal heart rate which can assist in excluding fetal compromise. If concern remains, despite normal CTG, urgent (within 24 hours) ultrasound can be used. If between 24 and 28 weeks gestation, a handheld Doppler should be used to confirm the presence of fetal heartbeat. If below 24 weeks gestation, and fetal movements have previously been felt, a handheld Doppler should be used. If fetal movements have not yet been felt by 24 weeks, onward referral should be made to a maternal fetal medicine unit.

While reduced fetal movements can be a cause for concern, in 70% of pregnancies with a single episode of reduced fetal movement, there is no onward complication. However, between 40-55% of women who suffer from stillbirth experience reduced fetal movements prior to diagnosis. Therefore, it is important for expectant mothers to be aware of their baby’s movements and seek medical attention if they notice a decrease in fetal movements.

Understanding Otosclerosis and its Effects on Hearing

Otosclerosis is a condition that leads to conductive deafness, which means that bone conduction is better than air conduction. When testing for this condition, you would expect to see bilateral negative Rinne with central Weber. However, if the disease is in its early stages, the Rinne test may be equivocal. It is important to note that the second and third options do not make sense in the context of otosclerosis. Understanding the effects of otosclerosis on hearing can help individuals seek appropriate treatment and management options.

PCV in addition to the 6-1 vaccine (which includes protection against diphtheria, tetanus, whooping cough, polio, Hib, and hepatitis B).

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at specific intervals. At 12-13 months, the Hib/Men C, MMR, PCV, and Men B vaccines are given. At 3-4 years, the ‘4-in-1 Preschool booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine is also offered to new students up to the age of 25 years at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine, while students going to university or college for the first time should contact their GP to have the vaccine before the start of the academic year.

The Men C vaccine used to be given at 3 months but has now been discontinued as there are almost no cases of Men C disease in babies or young children in the UK. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.

Pregnancy-induced hypertension is typically treated with Labetalol as the initial medication.

Pre-eclampsia is a condition that occurs during pregnancy and is characterized by high blood pressure, proteinuria, and edema. It can lead to complications such as eclampsia, neurological issues, fetal growth problems, liver involvement, and cardiac failure. Severe pre-eclampsia is marked by hypertension, proteinuria, headache, visual disturbances, and other symptoms. Risk factors for pre-eclampsia include hypertension in a previous pregnancy, chronic kidney disease, autoimmune disease, diabetes, chronic hypertension, first pregnancy, age over 40, high BMI, family history of pre-eclampsia, and multiple pregnancy. To reduce the risk of hypertensive disorders in pregnancy, women with high or moderate risk factors should take aspirin daily. Management involves emergency assessment, admission for severe cases, and medication such as labetalol, nifedipine, or hydralazine. Delivery of the baby is the most important step in management, with timing depending on the individual case.

Understanding Nephrotic Syndrome: Causes and Mechanisms

Nephrotic syndrome is a condition characterized by proteinuria, hypoalbuminemia, edema, and hyperlipidemia. The primary causes of nephrotic syndrome include minimal-change nephropathy, focal glomerulosclerosis, and membranous nephropathy, while secondary causes include systemic diseases and drugs. Membranous glomerulonephritis is the most common cause of nephrotic syndrome in adults.

The glomerular structural changes that may cause proteinuria involve damage to the endothelial surface, the glomerular basement membrane, or the podocytes. In membranous glomerulonephritis, immune complexes localize between the outer aspects of the basement membrane and the podocytes.

If left untreated, nephrotic syndrome can progress to end-stage renal failure in 30-50% of patients. However, some patients with idiopathic membranous nephropathy may experience complete or partial spontaneous remission of nephrotic syndrome with stable renal function.

It is important to differentiate nephrotic syndrome from other kidney conditions such as diffuse proliferative glomerulonephritis, IgA nephropathy, acute tubular necrosis, and acute interstitial nephritis. Understanding the causes and mechanisms of nephrotic syndrome can aid in proper diagnosis and treatment.

The combination of a monoamine oxidase inhibitor and pseudoephedrine may lead to a dangerous increase in blood pressure known as a hypertensive crisis.

Acute sinusitis is a condition where the mucous membranes of the paranasal sinuses become inflamed. This inflammation is usually caused by infectious agents such as Streptococcus pneumoniae, Haemophilus influenza, and rhinoviruses. Certain factors can predispose individuals to this condition, including nasal obstruction, recent local infections, swimming/diving, and smoking. Symptoms of acute sinusitis include facial pain, nasal discharge, and nasal obstruction. Treatment options include analgesia, intranasal decongestants or nasal saline, and intranasal corticosteroids. Oral antibiotics may be necessary for severe presentations, but they are not typically required. In some cases, an initial viral sinusitis can worsen due to secondary bacterial infection, which is known as double-sickening.

Vaccination for Children with Congenital Heart Diseases

Children with congenital heart diseases should be vaccinated in most situations. There is no contraindication to vaccination unless the child is actively febrile, and vaccination should not be deferred. Even if a child is born prematurely and not adjusted to the predicted date of birth, they should still be vaccinated per the normal schedule. Live vaccines, such as the measles, mumps, rubella vaccine (MMR), are given together and do not seem to reduce the immune response. However, single component vaccines for the MMR are not available through the NHS. It is important to prioritize vaccination for children with congenital heart diseases to protect them from preventable diseases.